Instructions for Ascoril Expectorant (Bromhexine, Guaifenesin, Albuterol)
English product name
Ascoril expectorant
Release form
Sirop
Infusion solution
Description:
Syrup in the form of transparent, orange color, viscous liquid with a specific smell.
10ml
bromhexine hydrochloride 4 mg
gwaifenezin 100 mg
salbutamol (in the form of salbutamol sulphate) 2 mg
Auxiliary substances: sucrose (sugar),
sorbitol (70% solution),
glycerol (glycerin),
propylene glycol,
sodium benzoate,
citric acid monohydrate,
sorbic acid,
sunflower sunset yellow (FCF) dye,
menthol (levomentol),
aromatizator blackcurrant (black currant ID 20158),
aromatizator pineapple (pineapple super "PH"),
water purified.
ATC codes
R05C Expectorants (excluding combinations with cough preparations)
Clinical-pharmacological groups / Group affiliation
Preparation with mucolytic, expectorant and broncholytic action
Active substance
bromhexine hydrochloride
gwaifenezin
salbutamol (sulphate)
Pharmacotherapy group:
Expectorant combined agent
Storage Conditions:
The drug Ascoril should be stored in the original packaging in a place not accessible to children at a temperature not higher than 25 ° C.
Best before date
Shelf life is 2 years. Do not use the drug Ascoril Expectorant after the expiry date.
Testimony:
For the symptomatic treatment of productive cough associated with various respiratory diseases, including, among others, the following:
acute bronchitis, including tracheobronchitis;
acute bronchitis caused by respiratory viruses;
Chronic bronchitis without additional specification (BDU);
chronic obstructive pulmonary disease (COPD);
asthma bronchitis;
pneumonia.
Method of use, course and dosage:
The drug Ascoril Expectorant is taken inside.
Adults and children over 12 years old are prescribed 10 ml 3 times/day.
Children aged 6 to 12 years - 5-10 ml 3 times/day; Children aged 2 to 6 years - 5 ml 3 times/day.
It is recommended to use a measuring cap.
Before drinking a bottle of syrup or solution must be shaken.
The drug Ascoril Expectorant should be used no more than four to five days. If symptoms persist for more than four to five days, the patient should see a doctor.
Application for kidney disorders
Use in renal failure is contraindicated.
Use in liver disorders
Use in liver failure is contraindicated.
Terms of Sale
The drug Ascoril Expectorant is prescription.
Use in children
Use in children under 2 years of age is contraindicated.
- Nosology (ICD codes)
- J04
- Acute laryngitis and tracheitis
- J15
- Bacterial pneumonia not classified elsewhere
- J20
- Acute bronchitis
- J37
- Chronic laryngitis and laryngotracheitis
- J42
- Chronic bronchitis unspecified
- J44
- Other chronic obstructive pulmonary disease
- J45
- Asthma
Pharmacological effects of expectorant:
A combined preparation having broncholytic, expectorant and mucolytic effects.
The active substance Bromhexin is a mucolytic agent. Increases the serous component of bronchial secretion and activates the cilia of atrial fibrillation, thus providing the expectorant effect of the drug Ascoril Expectorant: reduction of sputum viscosity, increase of its volume and improvement of withdrawal.
Active ingredient Gwaifenezin - mucolytic and expectorant, reduces the viscosity of sputum, facilitates its removal and promotes the transition of unproductive cough to productive.
The active substance Salbutamol is a broncholytic agent and is a selective agonist of β2-adrenoreceptors. In therapeutic doses, the drug Ascoril Expectorant acts on the β2-adrenoreceptors of smooth bronchial musculature, preventing and/or eliminating bronchial spasm, thus reducing respiratory resistance and increasing lung capacity. The bronchial expansion of salbutamol (reversible airway obstruction) lasts from 4 to 5 hours.
